The Niva Bupa Health Insurance IPO is making headlines as it approaches its final subscription day. With significant interest from investors and a detailed reservation breakup, this article provides a comprehensive overview of the IPO, including the latest grey market premium (GMP), key dates, and essential details for potential investors.
Niva Bupa Health Insurance IPO Overview
The Niva Bupa Health Insurance IPO launched on November 7, 2024, and will close for subscriptions today, November 11, 2024. The total issue size is approximately ₹2,200 crore, consisting of a fresh issuance of shares and an offer for sale (OFS).
Key Details of the IPO
- Total Shares Offered: 29,72,97,298 shares
- Price Band: ₹70 to ₹74 per share
- Lot Size: Minimum of 200 shares
- Minimum Investment for Retail Investors: ₹14,800
- Total Issue Size: ₹2,200 crore (₹800 crore fresh issue and ₹1,400 crore OFS)
Reservation Breakup
The shares are allocated as follows:
- Qualified Institutional Buyers (QIB): 30% (8,91,89,190 shares)
- Non-Institutional Investors (NII): 15% (4,45,94,595 shares)
- Retail Individual Investors (RII): 10% (2,97,29,730 shares)
- Anchor Investors: 45% (13,37,83,783 shares)
Latest GMP and Subscription Status
As of today, the grey market premium for the Niva Bupa IPO is reported to be flat. This indicates that the shares are trading at no premium over the issue price. The GMP reflects investor sentiment and can influence potential listing prices.
Subscription Figures
On Day 2 of the subscription:
- Overall Subscription Rate: Approximately 71%
- Retail Individual Investors: Fully subscribed their quota
- Qualified Institutional Buyers: Subscribed 0.79 times
- Non-Institutional Investors: Subscribed 0.35 times
Important Dates to Remember
| Event | Date |
|---|---|
| IPO Opening Date | November 7, 2024 |
| IPO Closing Date | November 11, 2024 |
| Allotment Date | November 12, 2024 |
| Credit to Demat Accounts | November 13, 2024 |
| Listing Date | November 14, 2024 |
Registrar and Book Running Lead Managers
Kfin Technologies Limited has been appointed as the registrar for the Niva Bupa Health Insurance IPO. The book running lead managers include:
- Morgan Stanley India Company Pvt Ltd
- Axis Capital Limited
- ICICI Securities Limited
- HDFC Bank
- Motilal Oswal Investment Advisors
- Kotak Mahindra Capital Company Limited
Should You Invest in Niva Bupa Health Insurance IPO?
Investing in an IPO requires careful consideration of various factors:
- Company Performance: Niva Bupa has shown promising growth with increasing revenue and a solid market presence in health insurance.
- Market Conditions: Current market trends and investor sentiment can significantly impact the performance of newly listed stocks.
- Investment Goals: Assess whether this investment aligns with your financial goals and risk tolerance.
Conclusion
As the Niva Bupa Health Insurance IPO approaches its closing date today, investors are keenly observing subscription rates and grey market trends. With a robust reservation breakup and significant institutional interest, this IPO presents an intriguing opportunity for investors looking to participate in India’s growing health insurance sector.
Disclaimer: This article is intended for informational purposes only and should not be considered financial advice. Investors should consult with financial advisors before making any investment decisions related to IPOs or other financial products.
